TFA
STIM icon

Transamerica Financial Advisors’s Neuronetics STIM Stock Holding History

Transamerica Financial Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154 Buy
+119
New +$173 ﹤0.01% 1923

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Transamerica Financial Advisors's STIM Position: Q2 2026 in Review

Transamerica Financial Advisors opened a new position in Neuronetics (STIM) in Q2 2026: 119 shares worth $154. The stake represents ﹤0.01% of the portfolio and ranks #1923 among its holdings.

87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Transamerica Financial Advisors held 119 shares of Neuronetics worth $154 as of Q2 2026.
  • Neuronetics was a new Transamerica Financial Advisors position in Q2 2026.
  • Neuronetics made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1923 holding.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.